Page 13 - HIV/AIDS Guidelines

HHS Panel on Antiretroviral Guidelines for Adults and
Adolescents Financial Disclosure (Last updated October 14, 2011; last

reviewed October 14, 2011)

Panel
Name Company Relationship
Status*
Daniel R. Kuritzkes M Abbott • Advisory Board
Avexa • Advisory Board
Boehringer Ingelheim • Advisory Board
Gilead • Advisory Board, Research Support
Human Genome Sciences • DSMB Member
Merck • Advisory Board, Research Support
Oncolys • Advisory Board
Roche • Advisory Board
Tobira • Advisory Board
Vertex • Consultant
ViiV • Advisory Board
ViroStatics • Advisory Board
VIRxSYS • Advisory Board

H. Clifford Lane C None N/A
Kendall Marcus C None N/A
Henry Masur M None N/A
Lynne Mofenson M None N/A

Heidi Nass M None N/A
Alice K. Pau ES None N/A
Richard W. Price M Abbott • Honoraria
Merck • Research Support
Michael Saag M Ardea Biosciences • Advisory Board, Research Support
Avexa • Advisory Board, Research Support
Boehringer Ingelheim • Advisory Board, Research Support
Bristol-Myers Squibb • Advisory Board, Research Support
Gilead • Advisory Board, Research Support
GlaxoSmithKline • Advisory Board, Research Support
Janssen Therapeutics • Advisory Board, Research Support
(formerly Tibotec Therapeutics)
Merck • Advisory Board, Research Support
Monogram Biosciences • Research Support
Pain Therapeutics • Consultant
Pfizer • Advisory Board, Research Support,
Consultant
ViiV • Advisory Board, Research Support
Vertex • Advisory Board, Consultant

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents xi

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.